The Fast Money traders share their final trades of the day.» Read More
Stocks ended flat in quiet trading Monday as investors continued to monitor developments in the Greek debt negotiations and ahead of the Fed's two-day FOMC meeting this week.
U.S. stock index futures wavered in a narrow range Monday as investors waited on news from the euro zone finance ministers and officials on the terms of a Greek debt restructuring as well as other issues in the euro zone debt crisis.
Stocks ended mixed in a quiet session Friday as investors were reluctant to jump in ahead of a weekend and after a handful of weak earnings reports weighed on sentiment. Despite the lackluster session, stocks still capped a strong finish for the week, with all three major averages adding almost two percent each.
US stock index futures turned lower Friday as investors kept a close watch on Greece as the debt-ridden nation remains in talks with private creditors over a haircut on some of its bonds and after GE's revenue missed forecast.
Stocks finished modestly higher Thursday, posting a three-day rally, thanks to a better-than-expected jobless claims report and as financials rallied following BofA's earnings report. Still, gains were largely muted throughout the session as investors hesitated to jump in following the recent run-up in stocks.
Apple has not revolutionized the textbook. They have revolutionized the textbook distribution model.
Stocks closed near highs of the session Wednesday with the S&P finishing at its highest level since July 2011, buoyed by an optimistic report on Greece, which added fuel to an earlier rally after a better-than-expected housing market report.
With a reported 200 million tweets posted every day, Twitter is unquestionably a great success - a global favorite - but we have some suggestions to make it even better for the users and followers.
Stock index futures cut their gains to turn flat Wednesday following a handful of tepid economic news and amid fears over the ongoing European debt crisis, but Goldman Sachs earnings helped limit losses.
Futures held their sharp gains Tuesday after the long holiday weekend, buoyed by a successful Spanish debt auction and higher than expected growth in China, but weaker-than-expected earnings from Citi limited gains.
Stocks bounced off their lows Friday, but still ended in negative territory amid expectations of an imminent S&P ratings downgrade of several euro zone countries. Despite the day's losses, stocks still posted a gain for the week.
Futures added to their losses Friday amid worries over a possible downgrade of several euro zone countries by the S&P and after JPMorgan posted earnings that missed on revenue outlook.
Stocks closed higher in thin trading Thursday, led by strength in materials and industrials, erasing losses after several weak economic reports from earlier in the session.
Futures came off their best levels Thursday after a weaker than expected jobless claims and a disappointing retail sales report, but held some gains after successful bond auctions in Europe which also pushed European stocks higher and sent the euro to a session high.
Stocks ended near session highs Wednesday, but still closed narrowly mixed, as worries over the euro zone and declines in the energy sector limited gains.
Futures edged lower Wednesday as the euro slipped following negative comments by Fitch and following the S&P 500's sharp rally in the previous session.
Wall Street kept its perfect streak in 2012 alive, closing solidly higher as investors looked to move beyond Europe's debt problems and gave U.S. banks a vote of confidence.
US stock index futures pointed to a higher open on Wall Street on Tuesday tracking European markets and buoyed by a positive outlook from US aluminum giant Alcoa after the bell on Monday.
The investigation into MF Global is intensifying as federal authorities unearth new details and confront potential obstacles in their hunt for roughly $1.2 billion in customer money that disappeared. The New York Times reports.
As the JPMorgan Health Care conference kicks off this week, one question remains for investors in the biotech space. What’s the next takeover target as large drug makers look to build out their pipeline?
Get the best of CNBC in your inbox